Malika Siker, MD

Associate Professor; Associate Dean for Student Inclusion and Diversity

Locations

Radiation Oncology

Contact Information

Education

MD, University of Wisconsin School of Medicine, Madison WI, 2006

Biography

Training

Residency, Radiation Oncology, Medical College of Wisconsin, Milwaukee WI (2007-2011)

Certifications

Radiation Oncology, American Board of Radiology (2012)

Patient Care Emphases

Pediatric brain tumors
Adult CNS tumors
Stereotactic radiosurgery
Lymphomas
Myelomas
Breast cancers

View Provider Profile

Halfway Toward Half Full.

(Siker M, Kavanagh BD.) Int J Radiat Oncol Biol Phys. 2019 Aug 01;104(5):997-998.
Erratum: Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville Jr C: Achieving Gender Equity in the Radiation Oncology Physician Workforce (Advances in Radiation Oncology 2018;3:478-483).

(.) Adv Radiat Oncol. 2019 Jan-Mar;4(1):210.
Achieving gender equity in the radiation oncology physician workforce.

(Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville C Jr.) Adv Radiat Oncol. 2018 Oct-Dec;3(4):478-483.
Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review.

(Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA.) Neurosurgery. 2018 05 01;82(5):595-603.
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT Histologies.

(Dhakal B, Fenske TS, Ramalingam S, Shuff J, Epperla N, Hosking P, Rein L, Banerjee A, Hari P, D'Souza A, Shah N, Siker M, Griepentrog GJ, Harris GJ, Wells TS, Erickson BA, Hamadani M.) Clin Lymphoma Myeloma Leuk. 2017 05;17(5):305-311.e2.
Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme.

(Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS.) J Neurooncol. 2015 May;123(1):179-88.
Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.

(Elson A, Bovi J, Siker M, Schultz C, Paulson E.) J Neurooncol. 2015 May;122(3):549-58.
Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites.

(Kainz K, Firat S, Wilson JF, Schultz C, Siker M, Wang A, Olson D, Li XA.) Phys Med Biol. 2015 Mar 21;60(6):2167-77.
Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal.

(Dayal A, Siker ML, Firat S, Bovi JA, Schultz CJ, Mueller WM, Connelly JM, Rand SD.) Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E103.
Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique.

(Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, Bovi JA.) Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E125-E126.
Spinal Cord Tumors

(Siker ML, Bovi J, Alexander B.) Clinical Radiation Oncology. 1 January 2015:521-540.e5.

Radiation Oncology